Table 2.

Data of patients being without evidence of disease after 2 years of follow-up

	Patient characteristics (gender, age at first diagnosis)	Tumor stage (TNM, UICC)	Therapy	Follow-up results
Patient 1	Female, 55 years	pT4b cN0 L0 V2 G4 R2, cM0	2/2013 Thyroidectomy, but macroscopic incomplete resection	86 months, no evidence of disease in 4/2020
		UICC stage IVB	3–5/2013 combined radiochemotherapy, radiotherapy: single fraction dose: 1.8 Gy, cumulative applied dose: 64.8 Gy
			Cisplatin 20 mg/m2 BSA d1–5, d29–33
Patient 2	Female, 29 years	pT3b, pN1a(8/25) R0 G3 Pn1 L1 V1 cM0, UICC stage IVB	2/2018: Thyroidectomy with complete tumor resection, 2–4/2018: combined radiochemotherapy: radiotherapy: single fraction dose: 2 Gy, cumulative applied dose: 66 Gy	30 months, no evidence of disease in 8/2020
			Cisplatin 20 mg/m2 BSA d1–5, d22–26, d43–47

BSA body surface area